dc.relation.reference | 1. The Website of American Cancer Society. Learn About Prostate Cancer. http://www.cancer.org/docroot/lrn/lrn_0.asp (2006).
2. Stamey, T. A. Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S. & Redwine, E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N. Engl. J. Med. 317, 909-16 (1987).
3. Feldman, B. J. & Feldman, D. The development of androgen-independent prostate cancer. Nat. Rev. Cancer 1, 34-45 (2001).
4. Shukeir, N., Garde, S., Wu, J. J., Panchal, C. & Rabbani, S. A. Prostate secretory protein of 94 amino acids (PSP-94) and its peptide (PCK3145) as potential therapeutic modalities for prostate cancer. Anticancer Drugs 16, 1045-51 (2005).
5. Annabi, B., Bouzeghrane, M., Currie, J. C., Hawkins, R., Dulude, H., Daigneault, L., Ruiz, M., Wisniewski, J. Garde, S., Rabbani, S. A. Panchal, C., Wu, J. J. & Beliveau, R. A PSP94-derived peptide PCK3145 inhibits MMP-9 secretion and triggers CD44 cell surface shedding: implication in tumor metastasis. Clin. Exp. Metastasis 22, 429-39 (2005).
6. Shukeir, N., Arakelian, A., Chen, G., Garde, S., Ruiz, M., Panchal, C. & Rabbani, S. A. A synthetic 15-mer peptide (PCK3145) derived from prostate secretory protein can reduce tumor growth, experimental skeletal metastases, and malignancy-associated hypercalcemia. Cancer Res. 64, 5370-7 (2004).
7. Abrahamsson, P. A. & Lilja, H. Three predominant prostatic proteins. Andrologia 22 Suppl.1, 122-31 (1990).
8. Nolet, S., St-Louis, D., Mbikay, M. & Chretien, M. Rapid evolution of prostatic protein PSP94 suggested by sequence divergence between rhesus monkey and human cDNAs. Genomics 9, 775-7. (1991).
9. Xuan, J. W., Wu, D., Guo, Y., Garde, S., Shum, D. T., Mbikay, M., Zhong, R. & Chin, J. L. Molecular cloning and gene expression analysis of PSP94 (prostate secretory protein of 94 amino acids) in primates. DNA Cell Biol. 16, 627-38 (1997).
10. Makinen, M., Valtonen-Andre, C. & Lundwall, A. New world, but not Old World, monkeys carry several genes encoding beta-microseminoprotein. Eur. J. Biochem. 264, 407-14 (1999).
11. Fernlund, P., Granberg, L. B. & Roepstorff, P. Amino acid sequence of beta-microseminoprotein from porcine seminal plasma. Arch. Biochem. Biophys. 309, 70-6 (1994).
12. Fernlund, P., Granberg, L. B. & Larsson, I. Cloning of beta-microseminoprotein of the rat: a rapidly evolving mucosal surface protein. Arch. Biochem. Biophys. 334, 73-82 (1996).
13. Xuan, J. W., Kwong, J., Chan, F. L., Ricci, M., Imasato, Y., Sakai, H., Fong, G. H., Panchal, C. & Chin, J. L. cDNA, genomic cloning, and gene expression analysis of mouse PSP94 (prostate secretory protein of 94 amino acids). DNA Cell Biol. 18, 11-26 (1999).
14. Lazure, C., Villemure, M., Gauthier, D., Naude, R. J. & Mbikay, M. Characterization of ostrich (Struthio camelus) beta-microseminoprotein (MSP): identification of homologous sequences in EST databases and analysis of their evolution during speciation. Protein Sci.10, 2207-18 (2001).
15. Garde, S., Sheth, A., Porter, A. T. & Pienta, K. J. Effect of prostatic inhibin peptide (PIP) on prostate cancer cell growth in vitro and in vivo. Prostate 22, 225-33 (1993).
16. Kamada, M., Mori, H., Maeda, N., Yamamoto, S., Kunimi, K., Takikawa, M., Maegawa, M., Aono, T., Futaki, S. & Koide, S. S. beta-Microseminoprotein/ prostatic secretory protein is a member of immunoglobulin binding factor family. Biochim. Biophys. Acta. 1388, 101-10 (1998).
17. Hyakutake, H., Sakai, H., Yogi, Y., Tsuda, R., Minami, Y., Yushita, Y., Kanetake, H., Nakazono, I. & Saito, Y. Beta-microseminoprotein immuno- reactivity as a new prognostic indicator of prostatic carcinoma. Prostate 22, 347-55 (1993).
18. Garde, S. V., Sheth, A. R., Porter, A. T. & Pienta, K. J. A comparative study on expression of prostatic inhibin peptide, prostate acid phosphatase and prostate specific antigen in androgen independent human and rat prostate carcinoma cell lines. Cancer Lett. 70, 159-66 (1993).
19. Shukeir, N., Arakelian, A., Kadhim, S., Garde, S. & Rabbani, S. A. Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer. Cancer Res. 63, 2072-8 (2003).
20. Nam, R. K., Reeves, J. R. Toi, A., Dulude, H., Trachtenberg, J., Emami, M., Daigneault, L., Panchal, C., Sugar, L., Jewett, M. A. & Narod, S. A. A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosis. J. Urol. 175, 1291-7 (2006).
21. Schroder, F. H. Prostate specific antigen and other markers for prostate cancer. J. Urol. 175, 1199-200 (2006).
22. Xu, K., Wang, X., Ling, M. T., Lee, D. T., Fan, T., Chan, F. L., Xuan, J. J., Tsao, S. W. & Wong, Y. C. Identification of a specifically expressed modified form of novel PSP-94 protein in the secretion of benign prostatic hyperplasia. Electrophoresis 24, 1311-8 (2003).
23. Chao, C. F., Chiou, S. T., Jeng, H. & Chang, W. C. The porcine sperm motility inhibitor is identical to beta-microseminoprotein and is a competitive inhibitor of Na+, K+-ATPase. Biochem. Biophys. Res. Commun. 218, 623-8 (1996).
24. Chao, C. F. The biochemical studies of sperm motility inhibitors from porcines seminal plasma. Doctoral dissertation, Institute of Biochemical Sciences, NTU (1997).
25. Wang, I., Yu, T. A., Wu, S. H., Chang, W. C. & Chen, C. Disulfide pairings and secondary structure of porcine beta-microseminoprotein. FEBS Lett. 541, 80-4 (2003).
26. Wang, I., Lou, Y. C., Wu, K. P., Wu, S. H., Chang, W. C. & Chen, C. Novel solution structure of porcine beta-microseminoprotein. J. Mol. Biol. 346, 1071-82 (2005).
27. Holm, L. & Sander, C. Touring protein fold space with Dali/FSSP. Nucleic Acids Res. 26, 316-9 (1998).
28. Orengo, C. A., Michie, A. D., Jones, S., Jones, D. T., Swindells, M. B. & Thornton, J. M. CATH-a hierarchic classification of protein domain structures. Structure 5, 1093-108 (1997).
29. Shindyalov, I. N. & Bourne, P. E. Protein structure alignment by incremental combinatorial extension (CE) of the optimal path. Protein Eng. 11, 739-47 (1998).
30. Ghasriani, H., Teilum, K., Johnsson, Y., Fernlund, P. & Drakenberg, T. Solution Structures of Human and Porcine beta-Microseminoprotein. J. Mol. Biol. 362, 502-15 (2006).
31. Yang, J. P., Finkelman, M. A. & Clarke, M. W. Detection of PSP94 and its specific binding sites in the prostate adenocarcinoma cell line LNCaP. J. Urol. 160, 2240-4 (1998).
32. Mundle, S. D. & Sheth, N. A. Suppression of DNA synthesis and induction of apoptosis in rat prostate by human seminal plasma inhibin (HSPI). Cell Biol. Int. 17, 587-94 (1993).
33. Lamy, S., Ruiz, M. T., Wisniewski, J., Garde, S., Rabbani, S. A., Panchal, C., Wu, J. J. & Annabi, B. A prostate secretory protein94-derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: implication in tumor angiogenesis. Int. J. Cancer 118, 2350-8 (2006).
34. Thakur, A. N., Vaze, A. Y., Dattatreyamurthy, B. & Sheth, A. R. Isolation & characterization of inhibin from human seminal plasma. Indian J. Exp. Biol. 19, 307-13 (1981).
35. Weiber, H., Borch, K., Sundler, F. & Fernlund, P. Beta-microseminoprotein in gastric carcinoids: a marker of tumour progression. Digestion 60, 440-8 (1999).
36. Thompson, J. D., Higgins, D. G. & Gibson, T. J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22, 4673-80 (1994).
37. Hall, T. A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41, 95-8 (1999).
38. Rance, M., Sorensen, O. W., Bodenhausen, G., Wagner, G., Ernst, R. R. & Wuthrich, K. Improved spectral resolution in COSY 1H NMR spectra of proteins via double quantum filtering. Biochem. Biophys. Res. Commun. 117, 479-485. (1983).
39. Bax, A. & Davis, D. G. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65, 355-360 (1985).
40. Kumar, A., Ernst, R. R. & Wuthrich, K. A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. Biochem. Biophys. Res. Commun. 95, 1-6 (1980).
41. Kay, L. E. Pulsed field gradient multi-dimensional NMR methods for the study of protein structure and dynamics in solution. Prog. Biophys. Mol. Biol. 63, 277-99. (1995).
42. Hwang, T. L., van Zijl, P. C. & Mori, S. Accurate quantitation of water-amide proton exchange rates using the phase-modulated CLEAN chemical EXchange (CLEANEX-PM) approach with a Fast-HSQC (FHSQC) detection scheme. J. Biomol. NMR 11, 221-6 (1998).
43. Wishart, D. S., Bigam, C. G., Yao, J., Abildgaard, F., Dyson, H. J., Oldfield, E., Markley, J. L. & Sykes, B. D. 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J. Biomol. NMR 6, 135-40 (1995).
44. Prestegard, J. H., Bougault, C. M. & Kishore, A. I. Residual dipolar couplings in structure determination of biomolecules. Chem. Rev. 104, 3519-40 (2004).
45. Ramirez, B. E., Voloshin, O. N., Camerini-Otero, R. D. & Bax, A. Solution structure of DinI provides insight into its mode of RecA inactivation. Protein Sci. 9, 2161-9 (2000).
46. Baber, J. L., Libutti, D., Levens, D. & Tjandra, N. High precision solution structure of the C-terminal KH domain of heterogeneous nuclear ribonucleoprotein K, a c-myc transcription factor. J. Mol. Biol. 289, 949-62 (1999).
47. Williams, D. C., Jr., Cai, M. & Clore, G. M. Molecular basis for synergistic transcriptional activation by Oct1 and Sox2 revealed from the solution structure of the 42-kDa Oct1.Sox2.Hoxb1-DNA ternary transcription factor complex. J. Biol. Chem. 279, 1449-57 (2004).
48. Brunner, E. Residual dipolar couplings in protein NMR. Concepts in Magnetic Resonace 13, 238-259 (2001).
49. Clore, G. M., Gronenborn, A. M. & Tjandra, N. Direct structure refinement against residual dipolar couplings in the presence of rhombicity of unknown magnitude. J. Magn. Reson. 131, 159-62 (1998).
50. Clore, G. M., Gronenborn, A. M. & Bax, A. A robust method for determining the magnitude of the fully asymmetric alignment tensor of oriented macromolecules in the absence of structural information. J. Magn. Reson. 133, 216-21 (1998).
51. Hansen, M. R., Mueller, L. & Pardi, A. Tunable alignment of macromolecules by filamentous phage yields dipolar coupling interactions. Nat. Struct. Biol. 5, 1065-74 (1998).
52. Ottiger, M., Delaglio, F., Marquardt, J. L., Tjandra, N. & Bax, A. Measurement of dipolar couplings for methylene and methyl sites in weakly oriented macromolecules and their use in structure determination. J. Magn. Reson. 134, 365-9 (1998).
53. Cornilescu, G., Delaglio, F. & Bax, A. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR 13, 289-302. (1999).
54. Schwieters, C. D., Kuszewski, J. J., Tjandra, N. & Clore, G. M. The Xplor-NIH NMR molecular structure determination package. J. Magn. Reson. 160, 65-73 (2003).
55. Koradi, R., Billeter, M. & Wuthrich, K. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14, 51-5, 29-32 (1996).
56. Laskowski, R. A., Rullmannn, J. A., MacArthur, M. W., Kaptein, R. & Thornton, J. M. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8, 477-86 (1996).
57. Kay, L. E., Nicholson, L., Delaglio, F., Bax, A. and Torchia, D. Pulse sequences for removal of the effects of cross correlation between dipolar and chemical-shift anisotropy relaxation mechanisms on the measurement of heteronuclear T1 and T2 values in proteins. J. Magn. Resonance 97, 359-375. (1992).
58. Barbato, G., Ikura, M., Kay, L. E., Pastor, R. W. & Bax, A. Backbone dynamics of calmodulin studied by 15N relaxation using inverse detected two-dimensional NMR spectroscopy: the central helix is flexible. Biochemistry 31, 5269-78 (1992).
59. Johnson, B. A. & Blevins, R. A. NMRVIEW: a computer program for the visualization and analysis of NMR data. J. Biomol. NMR 4, 603-614 (1994).
60. Tjandra, N., Feller, S. E., Pastor, R. W. & Bax, A. Rotational diffusion anisotropy of human ubiquitin from 15N NMR relaxation. J. Am. Chem. Soc. 117, 12562-6 (1995).
61. Cole, R. & Loria, J. P. FAST-Modelfree: a program for rapid automated analysis of solution NMR spin-relaxation data. J. Biomol. NMR 26, 203-13 (2003).
62. Mandel, A. M., Akke, M. & Palmer, A. G., 3rd. Backbone dynamics of Escherichia coli ribonuclease HI: correlations with structure and function in an active enzyme. J. Mol. Biol. 246, 144-63 (1995).
63. Blackledge, M. Recent progress in the study of biomolecular structure and dynamics in solution from residual dipolar couplings. Progress in Nuclear Magnetic Resonance Spectroscopy 46, 23-61 (2005).
64. Sreerama, N. & Woody, R. W. Estimation of Protein Secondary Structure from Circular Dichroism Spectra: Comparison of CONTIN, SELCON, and CDSSTR Methods with an Expanded Reference Set. Anal. Biochem. 287, 252-260 (2000).
65. Case, D. A. Calibration of ring-current effects in proteins and nucleic acids. J Biomol NMR 6, 341-6 (1995).
66. Gouet, P. & Courcelle, E. ENDscript: a workflow to display sequence and structure information. Bioinformatics 18, 767-8 (2002).
67. Dandekar, S. P., Sheth, A. R. & Ghosh, D. Presence of specific receptor binding sites for inhibin in rat spermatids. Andrologia 15, 274-8 (1983).
68. Reeves, J. R., Xuan, J. W. Arfanis, K., Morin, C., Garde, S. V., Ruiz, M. T., Wisniewski, J., Panchal, C. & Tanner, J. E. Identification, purification and characterization of a novel human blood protein with binding affinity for prostate secretory protein of 94 amino acids. Biochem. J. 385, 105-14 (2005).
69. Udby, L., Lundwall, A., Johnsen, A. H., Fernlund, P., Valtonen-Andre, C., Blom, A. M., Lilja, H., Borregaard, N., Kjeldsen, L. & Bjartell, A. beta-Microseminoprotein binds CRISP-3 in human seminal plasma. Biochem. Biophys. Res. Commun. 333, 555-61 (2005).
70. Bork, P., Holm, L. & Sander, C. The immunoglobulin fold. Structural classification, sequence patterns and common core. J. Mol. Biol. 242, 309-20 (1994).
71. Shapiro, L., Kwong, P. D., Fannon, A. M., Colman, D. R. & Hendrickson, W. A. Considerations on the folding topology and evolutionary origin of cadherin domains. Proc. Natl. Acad. Sci. USA 92, 6793-7 (1995).
72. Cota, E., Steward, A., Fowler, S. B. & Clarke, J. The folding nucleus of a fibronectin type III domain is composed of core residues of the immunoglobulin-like fold. J. Mol. Biol. 305, 1185-94 (2001).
73. Hamill, S. J., Steward, A. & Clarke, J. The folding of an immunoglobulin-like Greek key protein is defined by a common-core nucleus and regions constrained by topology. J. Mol. Biol. 297, 165-78 (2000).
74. Arnesano, F., Banci, L., Bertini, I. & Thompsett, A. R. Solution structure of CopC: a cupredoxin-like protein involved in copper homeostasis. Structure 10, 1337-47 (2002).
75. Zhang, C. & Kim, S. H. A comprehensive analysis of the Greek key motifs in protein beta-barrels and beta-sandwiches. Proteins 40, 409-19 (2000).
76. Feige, M. J., Walter, S. & Buchner, J. Folding mechanism of the CH2 antibody domain. J. Mol. Biol. 344, 107-18 (2004).
77. Zhang, C. & Kim, S. H. The anatomy of protein beta-sheet topology. J. Mol. Biol. 299, 1075-89 (2000).
78. Guo, M., Teng, M., Niu, L., Liu, Q., Huang, Q. & Hao, Q. Crystal structure of the cysteine-rich secretory protein stecrisp reveals that the cysteine-rich domain has a K+ channel inhibitor-like fold. J. Biol. Chem. 280, 12405-12 (2005).
79. Neuwald, A. F., Aravind, L., Spouge, J. L. & Koonin, E. V. AAA+: A class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes. Genome Res. 9, 27-43 (1999).
80. Fukui, T., Eguchi, T., Atomi, H. & Imanaka, T. A membrane-bound archaeal Lon protease displays ATP-independent proteolytic activity towards unfolded proteins and ATP-dependent activity for folded proteins. J. Bacteriol. 184, 3689-98 (2002).
81. Gottesman, S. Proteases and their targets in Escherichia coli. Annu. Rev. Genet. 30, 465-506 (1996).
82. Van Dyck, L., Pearce, D. A. & Sherman, F. PIM1 encodes a mitochondrial ATP-dependent protease that is required for mitochondrial function in the yeast Saccharomyces cerevisiae. J. Biol. Chem. 269, 238-42 (1994).
83. Wang, N., Gottesman, S., Willingham, M. C., Gottesman, M. M. & Maurizi, M. R. A human mitochondrial ATP-dependent protease that is highly homologous to bacterial Lon protease. Proc. Natl. Acad. Sci. USA 90, 11247-51 (1993).
84. Gottesman, S. Genetics of proteolysis in Escherichia coli*. Annu. Rev. Genet. 23, 163-98 (1989).
85. Zehnbauer, B. A., Foley, E. C., Henderson, G. W. & Markovitz, A. Identification and purification of the Lon+ (capR+) gene product, a DNA-binding protein. Proc. Natl. Acad. Sci. USA 78, 2043-7 (1981).
86. Schmidt, R., Decatur, A. L., Rather, P. N., Moran, C. P., Jr. & Losick, R. Bacillus subtilis lon protease prevents inappropriate transcription of genes under the control of the sporulation transcription factor sigma G. J. Bacteriol. 176, 6528-37 (1994).
87. Rudyak, S. G., Brenowitz, M. & Shrader, T. E. Mg2+-linked oligomerization modulates the catalytic activity of the Lon (La) protease from Mycobacterium smegmatis. Biochemistry 40, 9317-23 (2001).
88. Stahlberg, H. et al. Mitochondrial Lon of Saccharomyces cerevisiae is a ring-shaped protease with seven flexible subunits. Proc. Natl. Acad. Sci. USA 96, 6787-90 (1999).
89. Goldberg, A. L., Moerschell, R. P., Chung, C. H. & Maurizi, M. R. ATP-dependent protease La (lon) from Escherichia coli. Methods Enzymol. 244, 350-75 (1994).
90. Burton, R. E., Baker, T. A. & Sauer, R. T. Nucleotide-dependent substrate recognition by the AAA+ HslUV protease. Nat. Struct. Mol. Biol. 12, 245-51 (2005).
91. Kim, Y. I., Levchenko, I., Fraczkowska, K., Woodruff, R. V., Sauer, R. T. & Baker, T. A. Molecular determinants of complex formation between Clp/Hsp100 ATPases and the ClpP peptidase. Nat. Struct. Biol. 8, 230-3 (2001).
92. Sousa, M. C., Trame, C. B., Tsuruta, H., Wilbanks, S. M., Reddy, V. S. & McKay, D. B. Crystal and solution structures of an HslUV protease-chaperone complex. Cell 103, 633-43 (2000).
93. Vasilyeva, O. V., Kolygo, K. B., Leonova, Y. F., Potapenko, N. A. & Ovchinnikova, T. V. Domain structure and ATP-induced conformational changes in Escherichia coli protease Lon revealed by limited proteolysis and autolysis. FEBS Lett. 526, 66-70 (2002).
94. Maurizi, M. R. Proteases and protein degradation in Escherichia coli. Experientia 48, 178-201 (1992).
95. Ebel, W., Skinner, M. M., Dierksen, K. P., Scott, J. M. & Trempy, J. E. A conserved domain in Escherichia coli Lon protease is involved in substrate discriminator activity. J. Bacteriol. 181, 2236-43 (1999).
96. Roudiak, S. G. & Shrader, T. E. Functional role of the N-terminal region of the Lon protease from Mycobacterium smegmatis. Biochemistry 37, 11255-63 (1998).
97. Dougan, D. A., Weber-Ban, E. & Bukau, B. Targeted delivery of an ssrA-tagged substrate by the adaptor protein SspB to its cognate AAA+ protein ClpX. Mol. Cell 12, 373-80 (2003).
98. Dougan, D. A., Reid, B. G., Horwich, A. L. & Bukau, B. ClpS, a substrate modulator of the ClpAP machine. Mol. Cell 9, 673-83 (2002).
99. Botos, I., Melnikov, E. E., Cherry, S., Tropea, J. E., Khalatova, A. G., Rasulova, F., Dauter, Z., Maurizi, M. R., Rotanova, T. V., Wlodawer, A. & Gustchina, A. The catalytic domain of Escherichia coli Lon protease has a unique fold and a Ser-Lys dyad in the active site. J. Biol. Chem. 279, 8140-8 (2004).
100. Amerik, A., Antonov, V. K., Gorbalenya, A. E., Kotova, S. A., Rotanova, T. V. & Shimbarevich, E. V. Site-directed mutagenesis of La protease. A catalytically active serine residue. FEBS Lett. 287, 211-4 (1991).
101. Rotanova, T. V., Melnikov, E. E., Khalatova, A. G., Makhovskaya, O. V., Botos, I., Wlodawer, A. & Gustchina, A. Classification of ATP-dependent proteases Lon and comparison of the active sites of their proteolytic domains. Eur. J. Biochem. 271, 4865-71 (2004).
102. Lupas, A. N. & Martin, J. AAA proteins. Curr. Opin. Struct. Biol. 12, 746-53 (2002).
103. Smith, C. K., Baker, T. A. & Sauer, R. T. Lon and Clp family proteases and chaperones share homologous substrate-recognition domains. Proc. Natl. Acad. Sci. USA 96, 6678-82 (1999).
104. Lee, A. Y., Hsu, C. H. & Wu, S. H. Functional domains of Brevibacillus thermoruber lon protease for oligomerization and DNA binding: role of N-terminal and sensor and substrate discrimination domains. J. Biol. Chem. 279, 34903-12 (2004).
105. Li, M., Rasulova, F., Melnikov, E. E., Rotanova, T. V., Gustchina, A., Maurizi, M. R. & Wlodawer, A. Crystal structure of the N-terminal domain of E. coli Lon protease. Protein Sci. 14, 2895-900 (2005).
106. Botos, I., Melnikov, E. E., Cherry, S., Khalatova, A. G., Rasulova, F. S., Tropea, J. E., Maurizi, M. R., Rotanova, T. V., Gustchina, A. & Wlodawer, A. Crystal structure of the AAA+ alpha domain of E. coli Lon protease at 1.9Å resolution. J. Struct. Biol. 146, 113-22 (2004).
107. Fu, G. K., Smith, M. J. & Markovitz, D. M. Bacterial protease Lon is a site-specific DNA-binding protein. J. Biol. Chem. 272, 534-8 (1997).
108. Aravind, L., Anantharaman, V., Balaji, S., Babu, M. M. & Iyer, L. M. The many faces of the helix-turn-helix domain: transcription regulation and beyond. FEMS Microbiol. Rev. 29, 231-62 (2005).
109. Gajiwala, K. S., Chen, H., Cornille, F., Roques, B. P., Reith, W. & Mach, B Structure of the winged-helix protein hRFX1 reveals a new mode of DNA binding. Nature 403, 916-21 (2000).
110. Liu, T., Lu, B., Lee, I., Ondrovicova, G., Kutejova, E. & Suzuki, C. K. DNA and RNA binding by the mitochondrial lon protease is regulated by nucleotide and protein substrate. J. Biol. Chem. 279, 13902-10 (2004). | en |